CMS seeks comments on survey regarding inpatient rehabilitation facilities

The Centers for Medicare & Medicaid Services (CMS) published a request for information on Nov. 20 asking healthcare providers for their assistance in designing and developing a survey on patient and family experiences with inpatient rehabilitation facilities.  Comments are due by 5 p.m. on Jan. 19, 2016. CMS noted that the National Quality Strategy created as part of the Patient Protection and Affordable Care Act focuses on improving the quality of care, improving the health of the U.S. population and reducing the cost of care. In addition, the NQS has the following six priorities: 1.     Making care safer by reducing harm caused by the delivery of care2.     Ensuring that each person and family are engaged as partners in their care3.     Promoting effective communication and coordination of care4.     Promoting the most effective prevention and treatment practices for the leading causes of mortality, starting with cardiovascular disease5.     Working with communities to promote wide use of best practices to enable healthy living6.     Making quality care more affordable for individuals, families, employers, and governments by developing new health care delivery models. CMS said it is developing the survey based on the NQS’s aims. The survey is different from previous CMS surveys because it focuses on patients who have significant rehabilitation needs. CMS defines inpatient rehabilitation facilities as “hospitals or units of acute care (or critical access) hospitals that provide intensive rehabilitation services to patients typically following an injury, illness, or surgery.” Click here for information on how to submit comments.
Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.